“Our research is the first to document the existence of pulmonary veno-occlusive disease, or PVOD, in dogs. PVOD is considered one of the most severe forms of pulmonary hypertension,” said Kurt Williams, from the Michigan State University.
PVOD is diagnosed in only about 10 per cent of pulmonary hypertension (PH) cases where no other cause of the disease has been determined, researchers said. Unfortunately, there are very few effective treatment options for PVOD and a lung transplant often becomes the best choice.
“PVOD might be more common in dogs than in people, but this has yet to be determined and needs to be looked at further,” Williams said.
Pulmonary hypertension develops because of abnormal blood vessels in the lungs, which makes it harder for the heart to push blood through and provide oxygen to the rest of the body. In cases of PVOD, the small veins in the lungs become blocked, increasing pressure in these blood vessels, and ultimately causing heart failure.
“The same process happens in canines,” Williams said. “These dogs also come in with similar symptoms as humans, yet because subtle changes in health may not be recognised as quickly in dogs, death can occur quickly once the animal is seen by a veterinarian.”
Symptoms include cough, increased rate of breathing, respiratory distress, loss of appetite and chronic fatigue. Fatal progression of the disease in humans can last up to two years. “PVOD is a poorly understood disease not just because it’s so rare, but also because there have been no other animals known to have the disease,” Williams said.
Williams said the discovery could be important for human medicine because the canine disease may serve as a model for human PVOD.
The study was published in the journal Veterinary Pathology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
